ASP Isotopes Inc.
About ASP Isotopes Inc.
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $23.8M
- Net income
- -$159.8M
- Total assets
- $498.0M
- Market cap
- $844.8M
- Gross margin
- 14.3%
- Operating margin
- -251.2%
- Net margin
- -670.2%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $23.8M
- Cost of revenue
- $20.4M
- Gross profit
- $3.4M
- Operating expenses
- $63.3M
- Operating income
- -$59.9M
- Income tax
- $282.0K
- Net income
- -$159.8M
- EPS (basic)
- $-2.11
- EPS (diluted)
- $-2.11
Balance sheet
- Total assets
- $498.0M
- Current assets
- $399.9M
- Total liabilities
- $235.1M
- Current liabilities
- $32.7M
- Shareholders’ equity
- $262.9M
Cash flow
- Operating cash flow
- -$37.8M
- Investing cash flow
- -$110.8M
- Financing cash flow
- $371.6M
- Net cash flow
- $223.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $844.8M
- EPS (diluted)
- $-2.11
- Shares outstanding
- 144.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 10, 2022
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $159.8M in FY2025.
- Revenue grew 705074% from FY2022 to FY2025.
- Gross margin of 14.3%, net margin -670.2%.
- Trading 58% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ASP Isotopes Inc..
Write a review
News about ASP Isotopes Inc.
News & sentiment via Polygon.io
